TRAJECTORY OF CARIPRAZINE TREATMENT EFFECTS ACROSS SCHIZOPHRENIA SYMPTOMS: POST HOC ANALYSIS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO- AND ACTIVE-CONTROLLED TRIAL

被引：0

作者：

Cutler, Andrew J. ^{[1
]}

Durgam, Suresh ^{[2
]}

Lu, Kaifeng ^{[2
]}

Ruth, Adam ^{[3
]}

Laszlovszky, Istvan ^{[4
]}

Nemeth, Gyoergy ^{[4
]}

Meltzer, Herbert Y. ^{[5
]}

机构：

[1] Florida Clin Res Ctr LLC, Bradenton, IL USA

[2] Forest Res Inst, Jersey City, NJ USA

[3] Prescott Med Commun Grp, Chicago, IL USA

[4] Gedeon Richter Plc, Budapest, Hungary

[5] Northwestern Feinberg Sch Med, Chicago, IL USA

来源：

SCHIZOPHRENIA BULLETIN | 2015年 / 41卷

关键词：

D O I：

暂无

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

2086005

引用

页码：S308 / S308

页数：1

共 50 条

[1] Cariprazine for Negative Symptoms of Schizophrenia: Pooled Post Hoc Analysis of 2 Randomized, Double-Blind, Placebo- and Active-Controlled Trials
Earley, Willie
Durgam, Suresh
Debelle, Marc
Laszlovszky, Istvan
Lu, Kaifeng
Nasrallah, Henry
NEUROPSYCHOPHARMACOLOGY, 2015, 40 : S233 - S234
[2] Cariprazine for negative symptoms of schizophrenia: pooled post hoc analysis of 2 randomized, double-blind, placebo- and active-controlled trials
Durgam, S.
Earley, W.
Lu, K.
Nemeth, G.
Laszlovszky, I.
Szatmari, B.
Edwards, J.
Nasrallah, H. A.
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S552 - S552
[3] Efficacy of Cariprazine Across Schizophrenia Symptoms: A Post Hoc Analysis of PANSS Data from a Phase III, Double-blind, Placebo- and Active-controlled Trial
Zukin, Stephen R.
Lieberman, Jeffrey A.
Cutler, Andrew J.
Lu, Kaifeng
Migliore, Raffaele
Laszlovszky, Istvan
Nemeth, Gyoergy
Durgam, Suresh
NEUROPSYCHOPHARMACOLOGY, 2013, 38 : S379 - S380
[4] Cariprazine in negative symptoms of schizophrenia: post hoc analyses of a fixed-dose, placebo- and active-controlled trial
Debelle, M.
Faradzs-zade, S.
Szatmari, B.
Nagy, K.
Nemeth, G.
Durgam, S.
Laszlovszky, I.
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S534 - S534
[5] Cariprazine in Acute Exacerbation of Schizophrenia: A Fixed-Dose, Phase 3, Randomized, Double-Blind, Placebo- and Active-Controlled Trial
Durgam, Suresh
Cutler, Andrew J.
Lu, Kaifeng
Migliore, Raffaele
Ruth, Adam
Laszlovszky, Istvan
Nemeth, Gyoergy
Meltzer, Herbert Y.
JOURNAL OF CLINICAL PSYCHIATRY, 2015, 76 (12) : E1574 - +
[6] Cariprazine in acute exacerbation of schizophrenia: a fixed-dose, randomised, double-blind, placebo- and active-controlled trial
Lieberman, J. A.
Cutler, A. J.
Wan, S.
Migliore, R.
Ruth, A.
Laszlovszky, I.
Nemeth, G.
Durgam, S.
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S477 - S478
[7] Cariprazine in Negative Symptoms of Schizophrenia: Post-hoc Analyses of a Fixed-dose Phase Iii, Randomized, Double-blind, Placebo-and Active-controlled Trial
Debelle, M.
Faradzs-zade, S.
Szatmari, B.
Nagy, K.
Nemeth, G.
Durgam, S.
Laszlovszky, I.
EUROPEAN PSYCHIATRY, 2015, 30
[8] Sustained remission with cariprazine treatment: post hoc analysis of a randomized, double-blind, schizophrenia relapse prevention trial
Correll, C. U.
Potkin, S. G.
Durgam, S.
Cheng, C. T.
Szatmari, B.
Laszlovszky, I.
Saliu, I.
Earley, W.
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S935 - S936
[9] CHARACTERISTICS ASSOCIATED WITH RELAPSE IN PATIENTS WITH SCHIZOPHRENIA: POST HOC ANALYSIS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, CARIPRAZINE RELAPSE PREVENTION TRIAL
Kunovac, Jelena
Kane, John
Durgam, Suresh
Chang, Cheng-Tao
Nemeth, Gyorgy
Laszlovszky, Istvan
Earley, Willie
SCHIZOPHRENIA BULLETIN, 2017, 43 : S165 - S166
[10] THE EFFICACY OF LUMATEPERONE 42 MG IN THE TREATMENT OF SCHIZOPHRENIA SYMPTOMS ASSOCIATED WITH SOCIAL FUNCTIONING: POST HOC ANALYSIS OF AN ACUTE PLACEBO- AND ACTIVE-CONTROLLED TRIAL
Vanover, Kimberly
Davis, Robert
Durgam, Suresh
Huo, Jason
Mates, Sharon
Satlin, Andrew
Harvey, Philip D.
SCHIZOPHRENIA BULLETIN, 2020, 46 : S123 - S123

← 1 2 3 4 5 →